OVID
Ovid Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$467.20M
P/E Ratio
—
EPS
$-0.23
Beta
-0.03
52W High
$3.10
52W Low
$0.27
50-Day MA
$2.20
200-Day MA
$1.54
Dividend Yield
—
Profit Margin
-240.10%
Forward P/E
1.79
PEG Ratio
0.00
About Ovid Therapeutics Inc
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $7.25M |
| Gross Profit (TTM) | $7.25M |
| EBITDA | $-42.17M |
| Operating Margin | -1712.00% |
| Return on Equity | -17.50% |
| Return on Assets | -21.80% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $1.00 |
| Price-to-Book | 3.58 |
| Price-to-Sales (TTM) | 64.42 |
| EV/Revenue | 56.67 |
| EV/EBITDA | -0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 845.00% |
| Shares Outstanding | $173.04M |
| Float | $101.22M |
| % Insiders | 7.44% |
| % Institutions | 35.64% |
Historical Volatility
HV 10-Day
60.07%
HV 20-Day
76.70%
HV 30-Day
91.34%
HV 60-Day
81.21%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.25 target)
11
BuyData last updated: 4/29/2026